Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
Authors
Keywords
-
Journal
Scientific Reports
Volume 3, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-04-18
DOI
10.1038/srep01686
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- The New Age of Virus Discovery: Genomic Analysis of a Novel Human Betacoronavirus Isolated from a Fatal Case of Pneumonia
- (2013) K. V. Holmes et al. mBio
- Two more cases of novel coronavirus are confirmed in UK
- (2013) J. Wise BMJ-British Medical Journal
- Patient dies from novel coronavirus in UK
- (2013) J. Wise BMJ-British Medical Journal
- Extended Protection against Phlebovirus Infection Conferred by Recombinant Adenovirus Expressing Consensus Interferon (DEF201)
- (2012) Brian B. Gowen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care
- (2012) Brian L Pearlman LANCET INFECTIOUS DISEASES
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines
- (2012) M. A. Muller et al. mBio
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
- (2012) S. van Boheemen et al. mBio
- Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action
- (2011) Jan Paeshuyse et al. Current Opinion in Virology
- Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model
- (2010) Yohichi Kumaki et al. ANTIVIRAL RESEARCH
- Ribavirin monitoring in chronic hepatitis C therapy: anaemia versus efficacy
- (2010) Etienne Brochot et al. ANTIVIRAL THERAPY
- Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever
- (2010) Daniel G. Bausch et al. CLINICAL INFECTIOUS DISEASES
- Cell Type Mediated Resistance of Vesicular Stomatitis Virus and Sendai Virus to Ribavirin
- (2010) Nirav R. Shah et al. PLoS One
- Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells
- (2008) Yohichi Kumaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The management of coronavirus infections with particular reference to SARS
- (2008) S. S. Y. Wong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started